| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |